Skip to main content
logo
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.970
+0.010 (0.25%)
At close: May 29, 2026, 4:00 PM EDT
4.080
+0.110 (2.77%)
After-hours: May 29, 2026, 6:38 PM EDT

Oramed Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
109.9764.02-19.15.09-37.76-12.26
Depreciation & Amortization
0.120.120.190.20.060.02
Stock-Based Compensation
5.545.994.054.2211.531.78
Other Adjustments
-129.74-77.373.25-17.1-0.80.04
Changes in Accounts Payable
1.461.133.53-2.23-0.380.69
Changes in Unearned Revenue
-2.96-2.11--1.34-0.7-0.9
Changes in Other Operating Activities
-1.11-0.93-0.330.870.14-0.48
Operating Cash Flow
-8.54-9.15-8.41-10.3-27.92-11.12
Capital Expenditures
-0.01-0.01-0.02-0.25-0.5-0.01
Sale of Property, Plant & Equipment
----0.02-
Purchases of Investments
-97.87-88.51-55.76-190.92-154.41-100
Proceeds from Sale of Investments
42.4103.13161.66118.14185.090.76
Other Investing Activities
-12.69-9.17-0.07-0-
Investing Cash Flow
-37.665.44105.82-73.0430.21-99.25
Long-Term Debt Issued
---99.55--
Long-Term Debt Repaid
---49.55-50--
Net Long-Term Debt Issued (Repaid)
---49.5549.55--
Issuance of Common Stock
---2.4311.5660.57
Repurchase of Common Stock
-4.56-4.74-2.48---
Net Common Stock Issued (Repurchased)
-4.56-4.74-2.482.4311.5660.57
Common Dividends Paid
-10.36-----
Other Financing Activities
---0--0.78-
Financing Cash Flow
-15.11-4.74-52.0451.9810.7860.57
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.01-0.03-0-0.05-0.060.01
Net Cash Flow
-61.31-8.4745.37-31.4113.01-49.79
Free Cash Flow
-8.55-9.15-8.43-10.55-28.41-11.13
FCF Margin
--457.70%--787.24%-1051.20%-1231.31%
Free Cash Flow Per Share
-0.20-0.22-0.21-0.26-0.73-0.29
Levered Free Cash Flow
69.262.26-65.2452.32-37.9410.98
Unlevered Free Cash Flow
-14.38-14.62-11.96-18.52-42.0911.64
SEC Filings: 10-K · 10-Q